FULGENT GENETICS, INC. Excess Tax Benefit from Share-based Compensation, Operating Activities
FULGENT GENETICS, INC. (FLGT) reported Excess Tax Benefit from Share-based Compensation, Operating Activities of $59.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2017-05-09
- FULGENT GENETICS, INC. excess tax benefit from share-based compensation, operating activities for the quarter ending 2017-03-31 was $59.00K.
| Period end | Excess Tax Benefit from Share-based Compensation, Operating Activities 3 month |
|---|---|
| 2017-03-31 | $59.00K 10-Q · filed 2017-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |